Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914)

P. Sonneveld; S. Suciu; P.W. Weijermans; M. Beksac; R. Neuwirtova; H.M. Lokhorst

Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914)

Translated title of the contribution: Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914)

P. Sonneveld, S. Suciu, P.W. Weijermans, M. Beksac, R. Neuwirtova, H.M. Lokhorst

Hematology/Van Creveldclinic

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914)
Original language	Undefined/Unknown
Pages (from-to)	895-902
Number of pages	8
Journal	British Journal of Haematology
Volume	115
Publication status	Published - 2001

Cite this

@article{efc3a1a8ea484233aa70b50578ee32d6,

title = "Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914)",

author = "P. Sonneveld and S. Suciu and P.W. Weijermans and M. Beksac and R. Neuwirtova and H.M. Lokhorst",

year = "2001",

language = "Undefined/Unknown",

volume = "115",

pages = "895--902",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell",

}

Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914). / Sonneveld, P.; Suciu, S.; Weijermans, P.W. et al.
In: British Journal of Haematology, Vol. 115, 2001, p. 895-902.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914)

AU - Sonneveld, P.

AU - Suciu, S.

AU - Weijermans, P.W.

AU - Beksac, M.

AU - Neuwirtova, R.

AU - Lokhorst, H.M.

PY - 2001

Y1 - 2001

M3 - Article

SN - 0007-1048

VL - 115

SP - 895

EP - 902

JO - British Journal of Haematology

JF - British Journal of Haematology

ER -